New substances 15,000 times more effective in destroying chemical warf... ( In an advance that could be used in ...)

New substances 15,000 times more effective in destroying chemical warfare agents

Date:8/8/2012

In an advance that could be used in masks to protect against nerve gas, scientists are reporting development of proteins that are up to 15,000 times more effective than their natural counterpart in destroying chemical warfare agents. Their report appears in ACS' journal Biochemistry.

Frank Raushel, David Barondeau and colleagues explain that a soil bacterium makes a protein called phosphotriesterase (PTE), which is an enzyme that detoxifies some pesticides and chemical warfare agents like sarin and tabun. PTE thus has potential uses in protecting soldiers and others. Natural PTE, however, works against only one of the two molecular forms of these chemical warfare agents, and it happens to be the less toxic form. The scientists thus set out to develop new versions of PTE that were more effective against the most toxic form.

To improve the enzyme's activity, Raushel and colleagues used an approach called "directed evolution." This technique imitates the way natural selection leads to improved forms of the biochemical substances in living things. In using directed evolution, the team made small random changes to the natural enzyme's chemical architecture and then tested resulting mutant enzymes for their ability to break down nerve agents. They isolated several mutants that fit the bill, including one that proved to be 15,000 times more effective than the natural enzyme.

'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

1

GOOD

Post Your Comments:

(Date:5/23/2013)... Even while being dragged to its destruction inside ... away, sending signals that thwart the development of ... in an early online publication at Nature ... encountered by tumors, the epidermal growth factor receptor ... international team led by scientists at The University ...

(Date:5/23/2013)... be tested in a clinical trial by a biomedical ... disease has failed to work with the same type ... results of a study by University of Florida researchers. ... with the Evelyn F. and William L. McKnight Brain ... of verifying promising research results before investing in clinical ...

(Date:5/23/2013)... researchers have used next generation genomic analysis to determine ... have similar genetic origins, which may help in predicting ... journal Cancer Research . , "This is the ... sequencing in adjacent Gleason patterns in the same tumor ... says ,John Cheville, M.D., Mayo Clinic pathologist and one ...

(Date:5/23/2013)... negative" carries a poor prognosis, with limited treatment options. ... cells the way it,s supposed to. New research from ... to chemotherapy, and identifies a mechanism to rectify that. ... PhD, and his team at Western,s Schulich School of ... functions to promote the death of cancer cells by ...

(Date:5/23/2013)... Rottenstein Law Group LLP, a New York-based nationwide mass ... Center at http://www.rotlaw.com/tylenol , dedicated to issues that ... filing lawsuits. , The painkiller Tylenol (acetaminophen) has ... to a 2009 report from the U.S. Food and ... warned consumers against using more than the recommended dose ...

Breaking Medicine News(10 mins):Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2 Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3 Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2 Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2

[0] When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs [0] Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study [0] Mayo Clinic genomic analysis lends insight to prostate cancer [0] Research identifies a way to make cancer cells more responsive to chemotherapy [0] Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center

... diets also associated with higher income levels, study finds ... higher levels of education and income tend to eat ... are less energy-dense (lower calorie/higher nutrient content), a U.S. ... lower rates of obesity, type 2 diabetes, cardiovascular disease ...

... Tech Rapid Alert System Enables Hospitals to Rapidly Notify Staff, Community ... ... Clark, New Jersey, May 1, 2009 -- Mobile Health Tech, the ... 2.0 of its Hospital Rapid Notification Alert System™. This new release ...

... Female Health Company (NYSE Amex: FHC ) today ... discuss its operating results for the second quarter and first ... Friday, May 8, 2009. The Company expects to report ... earlier the same day. Shareholders and other interested parties may ...

... IL Ankle sprains are a common injury after a fall, ... of those who suffer an ankle sprain will experience chronic ankle ... , A review article published in the May 2009 issue of ... (JAAOS) explains that tendon injuries to the ankle can be ...

... delicious and active Mediterranean lifestyle are curePALM BAY, Fla., ... more likely we are to maintain a healthy diet ... diet than that eaten in the Mediterranean?In his new ... ( published by iUniverse ), Ray Adamcik ...

... Over Prior YearNEW YORK, May 1 HMS (Nasdaq: ... March 31, 2009. For the first quarter of 2009, revenue increased ... period a year ago. Net income for the quarter was $5.7 ... of $3.2 million or $0.12 per fully diluted share for the ...

More Educated Choose Healthier Foods, But Pay More Hospital Rapid Alert System Supports Swine Flu Pandemic Communications The Female Health Company Schedules Second Quarter Conference Call for May 8, 2009 Chronic ankle pain may be more than just a sprain 'The Globe's Best Diet: The Metabolic Syndrome Cure'HMS Holdings Corp. Announces First Quarter 2009 Financial Results

(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering. In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering. A portion of the ...

(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...

(Date:5/23/2013)... 23, 2013 MGC Diagnostics Corporation (NASDAQ: ... company, today scheduled a conference call to discuss its ... 2013, ended April 30, 2013. The call will be ... The Company will report financial results for the second ... on Thursday, May 30, 2013. (Logo: ...

Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2 Nephros Announces Completion of Rights Offering 3 Nephros Announces Completion of Rights Offering 4 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4 MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2

[0] Nephros Announces Completion of Rights Offering [0] Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises [0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013

... CENTER VALLEY, Pa., Dec. 7, 2011 /PRNewswire-iReach/ ... leader in designing and delivering innovative solutions in ... announces the release of Acecide ® -C, a ... exclusively for use in the Olympus Endoscope Reprocessor, ...

... Dec. 7, 2011 Data from the MarginProbe pivotal ... San Antonio Breast Cancer Symposium. The results were ... Surgery, NYU Langone Medical Center, New York University, ... randomized study, adjunctive use of MarginProbe significantly improved ...

Cached Medicine Technology:Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection 2 Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection 3 MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium 2

Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium

100% Silicone Foley Catheter Kits 2-Way...

ULTRAMER Foley Catheter...

Foley Catheters (Latex) 2-Way...

Silicone Elastomer-Coated Latex Foley Catheters 3-Way...

Medicine Products:

DOVER 100% Silicone Foley Catheter Kits 2-Way DOVER ULTRAMER Foley Catheter ULTRAMER Foley Catheters (Latex) 2-Way DOVER Silicone Elastomer-Coated Latex Foley Catheters 3-Way